DLL3 CAR-T therapy

· Shenzhen Geno-Immune Medical Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DLL3 CAR-T therapy, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: DLL3 CAR-T Therapy Targeting Brain Tumors [Phase 1, Phase 2]